Half-year report · Q2
9627.TEDINET S100UY0P
Period2024-05-01 → 2024-10-31
Filed2024-12-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥214.9bn | 2024-05-01 → 2024-10-31 | Cons. | Net sales |
| Revenue | ¥399.8bn | 2023-05-01 → 2024-04-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥193.7bn | 2023-05-01 → 2023-10-31 | Cons. | Net sales |
| Operating income | ¥5.9bn | 2024-05-01 → 2024-10-31 | Cons. | Operating income |
| Operating income | ¥8.7bn | 2023-05-01 → 2023-10-31 | Cons. | Operating income |
| Ordinary income | ¥6.3bn | 2024-05-01 → 2024-10-31 | Cons. | Ordinary income |
| Ordinary income | ¥21.4bn | 2023-05-01 → 2024-04-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.3bn | 2023-05-01 → 2023-10-31 | Cons. | Ordinary income |
| Profit before tax | ¥6.7bn | 2024-05-01 → 2024-10-31 | Cons. | Income before income taxes |
| Profit before tax | ¥9.4bn | 2023-05-01 → 2023-10-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.2bn | 2024-05-01 → 2024-10-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.4bn | 2023-05-01 → 2024-04-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.3bn | 2023-05-01 → 2023-10-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.2bn | 2024-05-01 → 2024-10-31 | Cons. | Profit loss |
| Net income | ¥5.2bn | 2023-05-01 → 2023-10-31 | Cons. | Profit loss |
| Total assets | ¥296.0bn | at 2024-10-31 | Cons. | Assets |
| Total assets | ¥249.4bn | at 2024-04-30 | Cons. | Assets |
| Total assets | ¥242.9bn | at 2023-10-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥159.9bn | at 2024-10-31 | Cons. | Liabilities |
| Total liabilities | ¥114.0bn | at 2024-04-30 | Cons. | Liabilities |
| Net assets / equity | ¥136.1bn | at 2024-10-31 | Cons. | Net assets |
| Net assets / equity | ¥135.4bn | at 2024-04-30 | Cons. | Net assets |
| Net assets / equity | ¥129.8bn | at 2023-10-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥27.2bn | at 2024-10-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥48.6bn | at 2024-04-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥27.2bn | at 2024-10-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥48.4bn | at 2024-04-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥50.3bn | at 2023-10-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥46.2bn | at 2023-04-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥12.7bn | 2024-05-01 → 2024-10-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.0bn | 2023-05-01 → 2024-04-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥14.1bn | 2023-05-01 → 2023-10-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥54.0bn | 2024-05-01 → 2024-10-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥15.7bn | 2023-05-01 → 2024-04-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.8bn | 2023-05-01 → 2023-10-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥20.1bn | 2024-05-01 → 2024-10-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.1bn | 2023-05-01 → 2024-04-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.2bn | 2023-05-01 → 2023-10-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥91.75 | 2024-05-01 → 2024-10-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥324.64 | 2023-05-01 → 2024-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥149.66 | 2023-05-01 → 2023-10-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 46.0% | at 2024-10-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.3% | at 2024-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.4% | at 2023-10-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2024-05-01 → 2024-10-31 | ¥5.6bn |
| Otherother segments | revenue external | 2024-05-01 → 2024-10-31 | ¥5.5bn |
| Otherother segments | revenue intersegment | 2024-05-01 → 2024-10-31 | ¥24m |
| Otherother segments | segment ordinary income | 2024-05-01 → 2024-10-31 | −¥15m |
| Reconciling Itemsreconciling | revenue | 2024-05-01 → 2024-10-31 | −¥24m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-05-01 → 2024-10-31 | −¥24m |
| Reconciling Itemsreconciling | segment ordinary income | 2024-05-01 → 2024-10-31 | −¥5.0bn |
| jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segment | revenue | 2024-05-01 → 2024-10-31 | ¥186.4bn |
| jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segment | revenue external | 2024-05-01 → 2024-10-31 | ¥186.4bn |
| jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segment | segment ordinary income | 2024-05-01 → 2024-10-31 | ¥9.6bn |
| jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segment | revenue | 2024-05-01 → 2024-10-31 | ¥22.9bn |
| jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segment | revenue external | 2024-05-01 → 2024-10-31 | ¥22.9bn |
| jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segment | segment ordinary income | 2024-05-01 → 2024-10-31 | ¥1.7bn |
| —segment total | revenue | 2024-05-01 → 2024-10-31 | ¥214.9bn |
| —segment total | revenue external | 2024-05-01 → 2024-10-31 | ¥214.9bn |
| —segment total | revenue intersegment | 2024-05-01 → 2024-10-31 | ¥24m |
| —segment total | segment ordinary income | 2024-05-01 → 2024-10-31 | ¥11.3bn |
| Otherother segments | revenue | 2023-05-01 → 2023-10-31 | ¥5.7bn |
| Otherother segments | revenue external | 2023-05-01 → 2023-10-31 | ¥5.7bn |
| Otherother segments | revenue intersegment | 2023-05-01 → 2023-10-31 | ¥24m |
| Otherother segments | segment ordinary income | 2023-05-01 → 2023-10-31 | −¥49m |
| Reconciling Itemsreconciling | revenue | 2023-05-01 → 2023-10-31 | −¥24m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-05-01 → 2023-10-31 | −¥24m |
| Reconciling Itemsreconciling | segment ordinary income | 2023-05-01 → 2023-10-31 | −¥4.4bn |
| jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segment | revenue | 2023-05-01 → 2023-10-31 | ¥173.2bn |
| jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segment | revenue external | 2023-05-01 → 2023-10-31 | ¥173.2bn |
| jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segment | segment ordinary income | 2023-05-01 → 2023-10-31 | ¥12.5bn |
| jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segment | revenue | 2023-05-01 → 2023-10-31 | ¥14.8bn |
| jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segment | revenue external | 2023-05-01 → 2023-10-31 | ¥14.8bn |
| jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segment | segment ordinary income | 2023-05-01 → 2023-10-31 | ¥1.3bn |
| —segment total | revenue | 2023-05-01 → 2023-10-31 | ¥193.8bn |
| —segment total | revenue external | 2023-05-01 → 2023-10-31 | ¥193.7bn |
| —segment total | revenue intersegment | 2023-05-01 → 2023-10-31 | ¥24m |
| —segment total | segment ordinary income | 2023-05-01 → 2023-10-31 | ¥13.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 577
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase decrease in provision for directors bonuses ope cf | Prior1YTDDuration | 4000000 | JPY |
| Increase decrease in provision for directors bonuses ope cf | CurrentYTDDuration | -2000000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -47000000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -34000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 17000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 84000000 | JPY |
| Loss gain on investments in partnership ope cf | Prior1YTDDuration | -28000000 | JPY |
| Loss gain on investments in partnership ope cf | CurrentYTDDuration | -6000000 | JPY |
| Gain on donation of noncurrent assets ope cf | Prior1YTDDuration | -2000000 | JPY |
| Gain on donation of noncurrent assets ope cf | CurrentYTDDuration | -8000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | -18000000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YTDDuration | 6000000 | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYTDDuration | 43000000 | JPY |
| Loss gain on sales and retirement of noncurrent assets ope cf | Prior1YTDDuration | -250000000 | JPY |
| Loss gain on sales and retirement of noncurrent assets ope cf | CurrentYTDDuration | 34000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -286000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 2094000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -3232000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -3085000000 | JPY |
| Decrease increase in other assets ope cf | Prior1YTDDuration | 918000000 | JPY |
| Decrease increase in other assets ope cf | CurrentYTDDuration | 529000000 | JPY |
| Decrease increase in accounts receivable other ope cf | Prior1YTDDuration | -3557000000 | JPY |
| Decrease increase in accounts receivable other ope cf | CurrentYTDDuration | -1979000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 7759000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 5920000000 | JPY |
| Increase decrease in other liabilities ope cf | Prior1YTDDuration | 596000000 | JPY |
| Increase decrease in other liabilities ope cf | CurrentYTDDuration | 140000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 17381000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 17384000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 47000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 34000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -17000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -65000000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -3316000000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -4624000000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 14094000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 12729000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -3856000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -4266000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | 847000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | 621000000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | － | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -0 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 20000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 301000000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | -295000000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | -46471000000 | JPY |
| Payments of loans receivable inv cf | Prior1YTDDuration | -0 | JPY |
| Payments of loans receivable inv cf | CurrentYTDDuration | -103000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |